NOT FOR DISTRIBUTION
Header cover image

Viemed Healthcare

Market Cap

€329.8m

Last Updated

2021/04/14 19:14 UTC

Data Sources

Company Financials +

Executive Summary

Viemed Healthcare, Inc., through its subsidiaries, provides in-home durable medical equipment and post-acute respiratory healthcare services to patients in the United States. More Details


Snowflake Analysis

Flawless balance sheet with solid track record.

Share Price & News

How has Viemed Healthcare's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: VIJ is more volatile than 75% of German stocks over the past 3 months, typically moving +/- 10% a week.

Volatility Over Time: VIJ's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of German stocks.


Market Performance


7 Day Return

-4.7%

VIJ

0.9%

DE Healthcare

0.2%

DE Market


1 Year Return

47.7%

VIJ

0.6%

DE Healthcare

42.4%

DE Market

Return vs Industry: VIJ exceeded the German Healthcare industry which returned 0.6% over the past year.

Return vs Market: VIJ exceeded the German Market which returned 42.4% over the past year.


Shareholder returns

VIJIndustryMarket
7 Day-4.7%0.9%0.2%
30 Day-3.0%5.2%5.1%
90 Day13.1%-2.9%9.6%
1 Year47.7%47.7%2.6%0.6%47.0%42.4%
3 Yearn/a-27.9%-31.4%23.5%12.8%
5 Yearn/a-28.5%-33.1%51.0%29.5%

Long-Term Price Volatility Vs. Market

How volatile is Viemed Healthcare's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Viemed Healthcare undervalued compared to its fair value and its price relative to the market?

12.27x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Below Fair Value: VIJ (€8.2) is trading above our estimate of fair value (€4.17)

Significantly Below Fair Value: VIJ is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: VIJ is good value based on its PE Ratio (12.3x) compared to the DE Healthcare industry average (32.5x).

PE vs Market: VIJ is good value based on its PE Ratio (12.3x) compared to the German market (28.2x).


Price to Earnings Growth Ratio

PEG Ratio: VIJ's earnings are forecast to decline next year, so we can't calculate its PEG ratio.


Price to Book Ratio

PB vs Industry: VIJ is overvalued based on its PB Ratio (4.8x) compared to the DE Healthcare industry average (1.7x).


Future Growth

How is Viemed Healthcare forecast to perform in the next 1 to 3 years based on estimates from 5 analysts?

-40.4%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: VIJ's earnings are forecast to decline over the next 3 years (-40.4% per year).

Earnings vs Market: VIJ's earnings are forecast to decline over the next 3 years (-40.4% per year).

High Growth Earnings: VIJ's earnings are forecast to decline over the next 3 years.

Revenue vs Market: VIJ's revenue (12.9% per year) is forecast to grow faster than the German market (5.4% per year).

High Growth Revenue: VIJ's revenue (12.9% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if VIJ's Return on Equity is forecast to be high in 3 years time


Past Performance

How has Viemed Healthcare performed over the past 5 years?

34.0%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: VIJ has a large one-off gain of $5.8M impacting its December 31 2020 financial results.

Growing Profit Margin: VIJ's current net profit margins (24%) are higher than last year (10.6%).


Past Earnings Growth Analysis

Earnings Trend: VIJ's earnings have grown significantly by 34% per year over the past 5 years.

Accelerating Growth: VIJ's earnings growth over the past year (268.8%) exceeds its 5-year average (34% per year).

Earnings vs Industry: VIJ earnings growth over the past year (268.8%) exceeded the Healthcare industry 2%.


Return on Equity

High ROE: VIJ's Return on Equity (38.6%) is considered high.


Financial Health

How is Viemed Healthcare's financial position?


Financial Position Analysis

Short Term Liabilities: VIJ's short term assets ($47.2M) exceed its short term liabilities ($23.0M).

Long Term Liabilities: VIJ's short term assets ($47.2M) exceed its long term liabilities ($7.9M).


Debt to Equity History and Analysis

Debt Level: VIJ's debt to equity ratio (9.9%) is considered satisfactory.

Reducing Debt: VIJ's debt to equity ratio has reduced from 16.2% to 9.9% over the past 5 years.

Debt Coverage: VIJ's debt is well covered by operating cash flow (435.3%).

Interest Coverage: VIJ's interest payments on its debt are well covered by EBIT (41.2x coverage).


Balance Sheet


Dividend

What is Viemed Healthcare current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate VIJ's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate VIJ's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if VIJ's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if VIJ's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of VIJ's dividend in 3 years as they are not forecast to pay a notable one for the German market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

1.3yrs

Average management tenure


CEO

Casey Hoyt (43 yo)

3.33yrs

Tenure

US$2,167,644

Compensation

Mr. Casey Hoyt has been Director of Viemed Healthcare, Inc. since December 14, 2016 and serves as Chief Executive Officer. Mr. Hoyt served as Chief Executive Officer of Patient Home Monitoring Corp. from ...


CEO Compensation Analysis

Compensation vs Market: Casey's total compensation ($USD2.17M) is above average for companies of similar size in the German market ($USD922.49K).

Compensation vs Earnings: Casey's compensation has been consistent with company performance over the past year.


Leadership Team

Experienced Management: VIJ's management team is not considered experienced ( 1.3 years average tenure), which suggests a new team.


Board Members

Experienced Board: VIJ's board of directors are considered experienced (3.3 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 2.8%.


Top Shareholders

Company Information

Viemed Healthcare, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Viemed Healthcare, Inc.
  • Ticker: VIJ
  • Exchange: DB
  • Founded: 2006
  • Industry: Health Care Services
  • Sector: Healthcare
  • Market Cap: CA$494.914m
  • Listing Market Cap: CA$329.819m
  • Shares outstanding: 39.56m
  • Website: https://www.viemed.com

Number of Employees


Location

  • Viemed Healthcare, Inc.
  • 625 East Kaliste Saloom Road
  • Lafayette
  • Louisiana
  • 70508
  • United States

Listings


Biography

Viemed Healthcare, Inc., through its subsidiaries, provides in-home durable medical equipment and post-acute respiratory healthcare services to patients in the United States. The company offers respiratory...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/04/14 19:14
End of Day Share Price2021/04/14 00:00
Earnings2020/12/31
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.